BlackRock Investment Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $891K | Sell |
37,438
-64
| -0.2% | -$1.52K | ﹤0.01% | 2748 |
|
|
2016
Q3 | $1.38M | Buy |
37,502
+2,830
| +8% | +$104K | ﹤0.01% | 2446 |
|
|
2016
Q2 | $773K | Buy |
34,672
+3,021
| +10% | +$67.4K | ﹤0.01% | 2805 |
|
|
2016
Q1 | $658K | Sell |
31,651
-360
| -1% | -$7.48K | ﹤0.01% | 2757 |
|
|
2015
Q4 | $970K | Buy |
32,011
+320
| +1% | +$9.7K | ﹤0.01% | 2619 |
|
|
2015
Q3 | $783K | Sell |
31,691
-670
| -2% | -$16.6K | ﹤0.01% | 2778 |
|
|
2015
Q2 | $1.04M | Buy |
32,361
+3,487
| +12% | +$112K | ﹤0.01% | 2729 |
|
|
2015
Q1 | $1.03M | Sell |
28,874
-152
| -0.5% | -$5.43K | ﹤0.01% | 2498 |
|
|
2014
Q4 | $659K | Sell |
29,026
-6,837
| -19% | -$155K | ﹤0.01% | 2830 |
|
|
2014
Q3 | $696K | Sell |
35,863
-293
| -0.8% | -$5.69K | ﹤0.01% | 2764 |
|
|
2014
Q2 | $1.31M | Buy |
36,156
+6,448
| +22% | +$234K | ﹤0.01% | 2393 |
|
|
2014
Q1 | $1.15M | Sell |
29,708
-126
| -0.4% | -$4.89K | ﹤0.01% | 2394 |
|
|
2013
Q4 | $850K | Sell |
29,834
-586
| -2% | -$16.7K | ﹤0.01% | 2595 |
|
|
2013
Q3 | $1.09M | Buy |
30,420
+220
| +0.7% | +$7.88K | ﹤0.01% | 2370 |
|
|
2013
Q2 | $1.01M | Buy |
+30,200
| New | +$1.01M | ﹤0.01% | 2340 |
|